Physician profile
James R Gray
NPI 1841219938
$45,918.23
in general payments reported to CMS, 2019-2025
29 companies · $2,721 in 2025
The $2,721 reported for 2025 was more than what 92% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,953 · 2020: $230 · 2021: $411 · 2022: $24K · 2023: $14K · 2024: $1,050 · 2025: $2,721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Travel and Lodging: $4,715 · Food and Beverage: $2,447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,830.00 |
| Travel and Lodging | $4,714.77 |
| Food and Beverage | $2,446.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $31,248.11 | 2021-2023 | Pylarify |
| Boston Scientific Corporation | $3,075.25 | 2019-2025 | Spaceoar Vue System - 10ml |
| Reflexion Medical, INC. | $2,697.53 | 2022-2023 | Reflexion Medical Radiotherapy System |
| Genzyme Corporation | $2,614.31 | 2019 | |
| Elekta, INC. | $2,344.50 | 2025 | Elekta Medical Linear Accelerator |
| Palette Life Sciences, INC. | $1,376.08 | 2021-2023 | |
| Teleflex LLC | $1,102.55 | 2024-2025 | Barrigel |
| Accuray Incorporated | $251.33 | 2022 | |
| Blue Earth Diagnostics | $161.49 | 2021-2023 | |
| Genentech USA, INC. | $143.50 | 2019 | |
| Gt Medical Technologies, INC | $134.71 | 2023 | Gammatile |
| Myovant Sciences INC. | $120.05 | 2021 | |
| Profound Medical Corp. | $100.03 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $97.79 | 2023 | Imfinzi |
| Novocure INC. | $95.10 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioprotect Medical, INC. | $57.66 | 2024-2025 | Bioprotect Balloon Implant System |
| Merck Sharp & Dohme LLC | $47.97 | 2025 | Welireg, Keytruda |
| Amgen INC. | $42.89 | 2020 | |
| Amarin Pharma, INC. | $29.64 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $21.52 | 2025 | Evkeeza |
| Isoray, INC | $21.04 | 2019 | |
| Myriad Genetic Laboratories, INC. | $21.00 | 2021 | |
| Abbvie INC. | $19.89 | 2021 | |
| Celgene Corporation | $19.81 | 2020 | |
| Tactile Systems Technology INC | $18.84 | 2021 | |
| Janssen Biotech, INC. | $15.26 | 2020 | |
| Novartis Pharmaceuticals Corporation | $14.47 | 2025 | |
| Foundation Medicine, INC. | $13.25 | 2019 | |
| Novo Nordisk INC | $12.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.